AUTEM THERAPEUTICS
Autem Therapeutics provides cancer care. The company offers autem therapy that show promise in shrinking tumors while also enhancing quality of life and extending survival in early and advanced-stage patient populations. The company resets cancer cells by normalizing their metabolism and improving energy efficiency.
AUTEM THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Oncology
Founded:
2019-01-01
Address:
Hanover, New Hampshire, United States
Country:
United States
Website Url:
http://www.autemtherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Amazon Pound Sterling
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Investors List
Zentynel Frontier Investments
Zentynel Frontier Investments investment in Series A - Autem Therapeutics
Official Site Inspections
http://www.autemtherapeutics.com
- Host name: ec2-3-137-132-132.us-east-2.compute.amazonaws.com
- IP address: 3.137.132.132
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Autem Therapeutics"
Autem Therapeutics - The Autem Team
Co-founder and Chief Executive Officer (CEO) USA Experienced Chief Executive with global strategy, operations, clinical development, clinical trials and real-world data (RWD) analytics …See details»
Autem Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Autem Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Autem Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Autem Therapeutics provides cancer care. The company offers autem therapy that show promise in shrinking tumors while also enhancing …See details»
Autem Therapeutics - Autem’s Mission
Our electromagnetic (EM) frequency non-thermal treatment—the AutEMsys TM therapy—provides game changing support for all parties involved when cancer therapy is needed:. Patients don’t suffer a reduced quality of life with painful …See details»
Autem Therapeutics - LinkedIn
Autem Therapeutics is a privately held oncology therapeutic and bioelectric company headquartered in Hanover NH, USA that is developing a novel, non-invasive and non-toxic …See details»
Leadership Team - The Org
Autem Therapeutics' Leadership Team includes Lucas Batista Gabriel and 15 others.See details»
Autem Therapeutics - PitchBook
Autem Therapeutics General Information Description. Developer of an electromagnetic frequency non-thermal therapy treatment designed for cancer patients. The company's therapy treatment …See details»
Autem Therapeutics: Drug pipelines, Patents, Clinical trials - Synapse
Dec 3, 2023 Explore Autem Therapeutics with its drug pipeline, therapeutic area, technology platform, .See details»
AUTEM THERAPEUTICS RAISES $10 MILLION SERIES A-1 …
Jun 6, 2022 Hanover, NH and Sao Paulo, Brazil, June 06, 2022 (GLOBE NEWSWIRE) -- Autem Therapeutics LLC (“Autem Therapeutics” or “the Company”), an emerging oncology …See details»
Autem Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 6, 2022: Series A - Autem …See details»
Autem Medical Company Profile | Management and Employees …
Autem Medical Profile and History . Autem Medical is a startup digital company founded in 2017 in New Hampshire, USA, by Dr. Frederico Perego Costa, a medical oncologist trained at …See details»
Autem Therapeutics - Apollo.io
Autem Therapeutics is a privately held oncology therapeutic and bioelectric company headquartered in Hanover NH, USA that is developing a novel, non-invasive and non-toxic …See details»
Autem Therapeutics - Company Profile - Tracxn
Nov 18, 2024 Autem Therapeutics ranks 8th among 31 active competitors. 9 of its competitors are funded while 8 have exited. Overall, Autem Therapeutics and its competitors have raised …See details»
Autem’s Technology - Autem Therapeutics
In non-dividing cancer cells, the AutEMsys TM therapy destabilizes microtubules, thus reducing the mobility of mitochondria and starving cells of energy. This kills these cells without surgery …See details»
What is Autem Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Autem Therapeutics. Salaries, reviews, and more - all posted by employees working at Autem Therapeutics.See details»
Series A - Autem Therapeutics - 2022-06-06 - Crunchbase
Jun 6, 2022 Autem Therapeutics raised $10000000 on 2022-06-06 in Series A. Start Free Trial . Chrome ExtensionSee details»
AUTEM THERAPEUTICS RAISES $10 MILLION SERIES A-1 …
Jun 6, 2022 [email protected] . Author: Amy Howard Created Date: 6/6/2022 3:00:19 PM ...See details»
FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of …
2 days ago The Leukemia & Lymphoma Society (LLS) was an early champion and funder of CAR T-cell therapy . Rye Brook, N.Y., December 6, 2024 – The U.S. Food and Drug …See details»
Autem Therapeutics - Patient Experience
This revolutionary treatment is simple to administer and gentle on the patient. Healthcare providers simply insert a spoon-shaped antenna into the patient’s mouth to deliver a range of …See details»
Autem Therapeutics - News and Media
Jun 6, 2022 Autem Therapeutics raises $10 million Series A-1 financing for novel bioelectric cancer treatment platformSee details»